Hydroxychloroquine - safety in pregnancy
Impaired fertility is an important public health concern, especially in patients with immune-mediated rheumatic condiHydroxychloroquine (HCQ) is an antimalarial drug containing a 4-aminoquinoline radical, with immunomodulatory, antioxidant, anti-inflammatory and vascular protective effects, which is...
Main Authors: | Ramona Georgiana Varse, Nicolae Gica, Radu Botezatu, Gheorghe Peltecu, Anca Maria Panaitescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2022-03-01
|
Series: | Romanian Journal of Rheumatology |
Subjects: | |
Online Access: | https://rjr.com.ro/articles/2022.1/RJR_2022_1_Art-01.pdf |
Similar Items
-
Novel biomarkers in the differential diagnosis of preeclampsia and lupus flare in pregnancy
by: Ilinca Ilie, et al.
Published: (2022-06-01) -
Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
by: Peng-Cheng Liu, et al.
Published: (2024-04-01) -
Incidence of hypertensive disorders of pregnancy in Romania
by: Anca Maria Panaitescu, et al.
Published: (2020-10-01) -
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
by: Ruth Fernandez-Ruiz, et al.
Published: (2020-08-01) -
Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
by: Christian A. Devaux, et al.
Published: (2021-02-01)